Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Selenium or compound thereof
Reexamination Certificate
2004-12-23
2009-12-22
Arnold, Ernst V (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Selenium or compound thereof
C514S706000
Reexamination Certificate
active
07635491
ABSTRACT:
The invention concerns the use of at least a molecule containing selenium, in an amount corresponding to a daily dose of about 2 to 40 mg, even 80 mg of atomic selenium equivalent, on its own or combined with other synergetic molecules for controlling oxidative stress and excessive inflammatory reaction: zinc, vitamin E, vitamin C, iron binder, glutathione precursor, copper and/or copper input binder, for preparing a medicine for treating severe systemic inflammatory response syndrome, in particular any acute infectious condition endangering the patient's life whether of bacterial, parasitic, fungal or viral origin, and any condition corresponding to a severe onset of inflammatory pathology bringing about an exacerbation of cytokine secretion. The invention is applicable in human and veterinary medicine.
REFERENCES:
patent: WO 96/30007 (1996-10-01), None
patent: 98/33495 (1998-08-01), None
Abstract: Kirkley et al. Transfus Med 1998, 8(3), 195-204.
Thomson Analyst 1998, 123, 827-831.
Burke et al. Biological Trace Element Research 1992, 33, 151-3.
T. Zimmermann et al., “Selensubstitution bei Sepsispatienten. Eine prospektiv randomisierte Studie.”, Medizinische Klinik, Sep. 15, 1997, 92 Suppl 3 P3-4.
R. Gartner et al., “Selensubstitution bei Sepsispatienten” Medizinische Klinik, 92/Suppl. 3 (12-14).
J. Borner et al., “Selensubstitution bei schweren entzunddichen chirurgischen Krankheitsbildern sowie Verbrennungen und Verbruhungen im Kindesalter.” Medizinische Klinik, Sep. 15, 1997, 92 Suppl 3 P17-9.
Chemical Abstracts 108:149240 (Apr. 1988).
Chemical Abstracts 127:171274 (Sep. 1997).
Chemical Abstracts 129:134509 (Sep. 1998).
Medline Abstract, accession No. 89032644 (1988).
Chemical Abstracts, 116:150492 (1992).
Hofbauer, L.C. et al., “Selenium-induced thyroid dysfunction,” Postgraduate Medical Journal, vol. 73(856), Feb. 1997, pp. 103-104.
Medline Abstract, accession No. 89114296 (1989).
Forceville Xavier
Vitoux Dominique
Arnold Ernst V
Forceville Xavier
Young & Thompson
LandOfFree
Method for administering selenium for treating patients... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for administering selenium for treating patients..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for administering selenium for treating patients... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063867